CLEC16A and myeloid sarcoma: CLEC16A, variants of which are associated with susceptibility to MS, is involved in the control of TEC autophagy, a process that regulates MHC-associated thymic presentation of lysosomal, nuclear and mitochondrial peptide antigens [105, 106].